Payments to Acquire Property, Plant, and Equipment of RECURSION PHARMACEUTICALS, INC. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
RECURSION PHARMACEUTICALS, INC. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • RECURSION PHARMACEUTICALS, INC. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $1,832,000, a 72% decline year-over-year.
  • RECURSION PHARMACEUTICALS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $6,469,000, a 53% decline from 2024.
  • RECURSION PHARMACEUTICALS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $13,695,000, a 15% increase from 2023.
  • RECURSION PHARMACEUTICALS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $11,955,000, a 68% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

RECURSION PHARMACEUTICALS, INC. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $6,469,000 -$7,226,000 -53% 01 Jan 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
2024 $13,695,000 +$1,740,000 +15% 01 Jan 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
2023 $11,955,000 -$25,104,000 -68% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
2022 $37,059,000 -$2,739,000 -6.9% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025 2024 FY
2021 $39,798,000 +$33,967,000 +583% 01 Jan 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
2020 $5,831,000 +$1,921,000 +49% 01 Jan 2020 31 Dec 2020 10-K 27 Feb 2023 2022 FY
2019 $3,910,000 01 Jan 2019 31 Dec 2019 10-K 23 Mar 2022 2021 FY

RECURSION PHARMACEUTICALS, INC. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $1,832,000 -$4,821,000 -72% 01 Jan 2025 31 Mar 2025 10-Q 05 May 2025 2025 Q1
Q1 2024 $6,653,000 +$1,478,000 +29% 01 Jan 2024 31 Mar 2024 10-Q 05 May 2025 2025 Q1
Q1 2023 $5,175,000 +$833,000 +19% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $4,342,000 -$15,074,000 -78% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1
Q1 2021 $19,416,000 +$18,732,000 +2739% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q1 2020 $684,000 01 Jan 2020 31 Mar 2020 10-Q 12 May 2021 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.